This start-up uses artificial intelligence tech for breast cancer screening

Bengaluru-based Niramai uses machine learning and cloud-based screening as well, Tech in Asia

This start-up uses artificial intelligence tech for breast cancer screening
Sumit Chakraberty | Tech In Asia
Last Updated : Apr 24 2017 | 1:34 PM IST
One out of two women diagnosed with breast cancer dies within five years in India. In the US, the fatality is less than one out of five, and in China, one out of four – according to WHO(World Health Organization). Early detection is one of the main reasons for the fall in mortality rates in developed countries.

Shortages of facilities and radiographers coupled with the cost of regular screening, which most people find unaffordable in India, make this a massive problem. Breast cancer has overtaken cervical cancer as the leading cause of death from cancer among women in India.

Bangalore-based startup Niramai is using a combination of machine learning, artificial intelligence, and cloud-based screening to tackle the problem of access and cost of breast cancer screening. Last week on Tech in Asia, we had a brief description of Niramai in a list of 20 startups in the summer batch of Axilor, an accelerator in Bangalore. Today, Niramai announced seed funding led by Pi Ventures, with participation from Axilor Ventures, 500 Startups, Ankur Capital, and Flipkart co-founder Binny Bansal.

Niramai is an acronym for Non-Invasive Risk Assessment with Machine-learning and Artificial Intelligence. It uses a low-cost device that takes high-resolution thermal images which require no radiation. Artificial intelligence is applied to the images on the cloud to detect breast cancer. This provides an alternative to traditional mammography, which requires expensive equipment and experienced radiographers. The startup claims that its patented Thermalytix technology using thermography can detect tumors five years earlier than mammography or clinical exams.

AI is also preventing unnecessary biopsies from false positives of traditional clinical screening. Niramai’s thermal imagery and cloud-based analytics have the potential to extend the reach of AI for breast cancer screening around the world, not just in India.

This is an excerpt from the article published on Tech in Asia. You can read the full article here.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story